Table 4 PLI, 10 years – Description and comparison with the 1st examination (period 0 = Baseline). Number of implants (n)
| Â | Â | Â | Â | Â | Comparison with Baseline* | ||
|---|---|---|---|---|---|---|---|
Period | n | 0 | 1 | 2 | Coeff | 95%-KI | p value |
Baseline | 61 | 11 (18.0%) | 34 (55.7%) | 16 (26.2%) | – | – | – |
  ≤1 Y | 61 | 9 (14.8%) | 24 (39.3%) | 28 (45.9%) | 0.77 | 0.27–1.27 | 0.002 |
  ≤2 Y | 36 | 11 (30.6%) | 10 (27.8%) | 15 (41.7%) | 0.16 | − 0.42–0.74 | 0.582 |
  ≤3 Y | 39 | 4 (10.3%) | 17 (43.6%) | 18 (46.2%) | 0.69 | 0.10–1.28 | 0.022 |
  ≤4 Y | 31 | 7 (22.6%) | 16 (51.6%) | 8 (25.8%) | 0.05 | − 0.53–0.63 | 0.858 |
  ≤5 Y | 34 | 6 (17.6%) | 15 (44.1%) | 13 (38.2%) | 0.60 | − 0.00–1.21 | 0.051 |
  ≤6 Y | 23 | 6 (26.1%) | 9 (39.1%) | 8 (34.8%) | 0.55 | − 0.13–1.23 | 0.111 |
  ≤7 Y | 22 | 3 (13.6%) | 14 (63.6%) | 5 (22.7%) | 0.78 | 0.07–1.50 | 0.031 |
  ≤8 Y | 20 | 4 (20.0%) | 9 (45.0%) | 7 (35.0%) | 0.68 | − 0.07–1.44 | 0.075 |
  ≤9 Y | 17 | 2 (11.8%) | 10 (58.8%) | 5 (29.4%) | 0.78 | − 0.02–1.58 | 0.057 |
  ≤10 Y | 17 | 4 (23.5%) | 10 (58.8%) | 3 (17.6%) | 0.48 | − 0.31–1.26 | 0.232 |